These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9230455)

  • 1. A computer model and program for xenobiotic disposition during pregnancy.
    Luecke RH; Wosilait WD; Pearce BA; Young JF
    Comput Methods Programs Biomed; 1997 Jul; 53(3):201-24. PubMed ID: 9230455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiologically based pharmacokinetic computer model for human pregnancy.
    Luecke RH; Wosilait WD; Pearce BA; Young JF
    Teratology; 1994 Feb; 49(2):90-103. PubMed ID: 8016750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
    Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):395-414. PubMed ID: 2749729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylmercury distribution in the pregnant rat and embryo during early midbrain organogenesis.
    Lewandowski TA; Pierce CH; Pingree SD; Hong S; Faustman EM
    Teratology; 2002 Nov; 66(5):235-41. PubMed ID: 12397631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physiologically based pharmacokinetic model for methyl mercury in the pregnant rat and fetus.
    Gray DG
    Toxicol Appl Pharmacol; 1995 May; 132(1):91-102. PubMed ID: 7747289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological "constants" for PBPK models for pregnancy.
    Young JF; Branham WS; Sheehan DM; Baker ME; Wosilait WD; Luecke RH
    J Toxicol Environ Health; 1997 Dec; 52(5):385-401. PubMed ID: 9388532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic models in developmental toxicology.
    O'Flaherty EJ
    Risk Anal; 1994 Aug; 14(4):605-11. PubMed ID: 7972961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically-based pharmacokinetic model for pregnancy as a tool for investigation of developmental mechanisms.
    Young JF
    Comput Biol Med; 1998 Jul; 28(4):359-64. PubMed ID: 9805196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results.
    Jongeneelen FJ; Berge WF
    Ann Occup Hyg; 2011 Oct; 55(8):841-64. PubMed ID: 21998005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
    Hays SM; Elswick BA; Blumenthal GM; Welsch F; Conolly RB; Gargas ML
    Toxicol Appl Pharmacol; 2000 Feb; 163(1):67-74. PubMed ID: 10662606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impacts on fetal dosimetry of the modelling of the placental transfers of xenobiotics in a pregnancy physiologically based pharmacokinetic model.
    Codaccioni M; Brochot C
    Toxicol Appl Pharmacol; 2020 Dec; 409():115318. PubMed ID: 33160985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.
    Abduljalil K; Furness P; Johnson TN; Rostami-Hodjegan A; Soltani H
    Clin Pharmacokinet; 2012 Jun; 51(6):365-96. PubMed ID: 22515555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of methylmercury disposition in humans utilizing a PBPK model and animal pharmacokinetic data.
    Young JF; Wosilait WD; Luecke RH
    J Toxicol Environ Health A; 2001 May; 63(1):19-52. PubMed ID: 11346132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling.
    Lin Z; Fisher JW; Wang R; Ross MK; Filipov NM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):140-58. PubMed ID: 23958493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
    DeVane CL; Simpkins JW
    Drug Metab Dispos; 1985; 13(4):438-42. PubMed ID: 2863107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of xenobiotic chemicals in the maternal-fetal unit.
    Barr DB; Bishop A; Needham LL
    Reprod Toxicol; 2007; 23(3):260-6. PubMed ID: 17386996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based pharmacokinetic model of midazolam disposition during pregnancy.
    Andrew MA; Hebert MF; Vicini P
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5454-7. PubMed ID: 19163951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice.
    Ward KW; Blumenthal GM; Welsch F; Pollack GM
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):311-22. PubMed ID: 9266804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.
    Mitani GM; Steinberg I; Lien EJ; Harrison EC; Elkayam U
    Clin Pharmacokinet; 1987 Apr; 12(4):253-91. PubMed ID: 3297463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.